Mitsuhiro Ibe
President bij ZERIA PHARMACEUTICAL CO., LTD.
Vermogen: 1 M $ op 31-03-2024
Profiel
Mitsuhiro Ibe currently works at Tillotts Pharma AG, as Non Executive Director and Zeria Pharmaceutical Co., Ltd., as President, COO & Representative Director from 2014.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
31-03-2023 | 77 000 ( 0.14% ) | 1 M $ | 31-03-2024 |
Actieve functies van Mitsuhiro Ibe
Bedrijven | Functie | Begin |
---|---|---|
ZERIA PHARMACEUTICAL CO., LTD. | President | 01-06-2014 |
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Director/Board Member | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ZERIA PHARMACEUTICAL CO., LTD. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Health Technology |